While there may not be head-to-head trials between high-dose trivalent and standard-dose quadrivalent influenza vaccines, the high-dose is still the better option for adults aged 65 and older.
While details about the amendments were not immediately available, the OMA president suggested the changes would address concerns about fairness and due process